1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals

ESTENNE M.
In vitro T cell function after lung transplantation: suppression of the indirect
allorecognition pathway.
2ème Congrès International de Transplantation Pulmonaire, Paris, Septembre 1996
92. WISSING M, MORELON E, LEGENDRE C, ABRAMOWICZ D, LEBEAUT A,
GRINT P, MANISCALKI M, KREIS H, GOLDMAN M
A pilot trial of rhIL-10 in kidney transplant recipients receiving OKT3 induction therapy.
29th Annual Meeting of the American Society of Nephrology, New Orleans, USA,
November 1996.
93. VEREERSTRAETEN P, ANDRIEN M, ABRAMOWICZ D, DE PAUW L,
KINNAERT P
What is the best criterium for selecting recipients of a cadaver kidney transplant according
to HLA matching ?
International Society of Nephrology, Sydney, May 1997.
94. VEREERSTRAETEN P, ABRAMOWICZ D, DE PAUW L, KINNAERT P.
Absence of deleterious effect on long-term kidney graft survival of rejection episodes with
complete functional recovery.
International Society of Nephrology, Sydney, May 1997.
95. C. KNOOP, J.L. VACHIERY, M. ANTOINE, D. ABRAMOWICZ, M. ESTENNE.
Acute renal insufficiency requiring hemodialysis due to fenofibrate therapy in a heart-lung
transplant (HLT) recipient.
European Respiratory Society Annual Congress, Berlin, Septembre 1997.
96. A. LE MOINE, V. FLAMAND, JC. NOEL, I. FAYT, M. WISSING, F. DESALLE, ML.
VANDERHAEGEN, F. BULTE, M. GOLDMAN, D. ABRAMOWICZ
Chronic skin graft rejection across a single class II MHC antigen disparity: histological
characteristics and T cell reactivity.
Cinquième Basic Sciences Symposium de la Socièté de Transplantation, Chautauqua,
USA, Septembre 1997.
97. N. BROEDERS, A. CRUSIAUX, M. WISSING, L. DE PAUW, P. KINNAERT, P.
VEREERSTRAETEN, D. ABRAMOWICZ
Neoral and mycophenolate mofetil additively decrease the anti-OKT3 humoral response.
30th Annual Meeting of the American Society of Nephrology, San Antonio, Novembre
1997.
98. A. LE MOINE, V. FLAMAND, JC. NOEL, I. FAYT, M. WISSING, F. DESALLE, ML.
52